The World Health Organisation recently launched a campaign to reduce Hepatitis B Viral Infections by 80% globally. Achieving this goal is partly predicated on proper awareness of persons in regions of high transmission. The aim of this study was to assess the Hepatitis B Virus (HBV) infection knowledge status of persons across three states in Nigeria. A descriptive cross-sectional study among 758 persons selected by convenience sampling was conducted from March to July 2016. Structured questionnaires were administered to consenting participants and analysed using descriptive and inferential statistical methods in SPSS V20. Respondents showed average knowledge with a mean knowledge score of 4.85 ± 2.69 out of a max score of 9.00. Respondents belonging to the working class had significantly better knowledge (5.59 ± 2.34 p < 0.001) than respondents in other categories. High-risk behaviour such as having multiple partners was predominant among respondents belonging to a public institution. A total of 242 (31.96%) of study respondents were aware of the existence of a vaccine for HBV, whereas only 161 (21.2%) had received at least one dose of vaccination against HBV. Previous knowledge of HBV infection, previous HBV testing, and knowing someone who had HBV infection were predictors of HBV infection knowledge as well as vaccination. This study has shown the urgent need for intervention targeted at raising awareness about HBV infection and the existence of a vaccine.

Begomoviruses are a major threat to cassava production in Africa. Indeed, during the 1990s, the emergence of a recombinant begomovirus (East African cassava mosaic virus-Uganda, EACMV-Ug) resulted in crop devastation and severe famine in Uganda. In 2023, during a pre-survey of cassava farms at Forécariah, South-West Guinea, 22 samples showing peculiar cassava mosaic disease (CMD) symptoms were collected, and subsequent laboratory analysis confirmed the presence of EACMV-Ug in the samples. Deep analysis of DNA-A and DNA-B of the EACMV-Ug isolates from Guinea indicated that they are similar to those associated with the severe CMD epidemic in Uganda in the 1990s. Therefore, a country-wide survey was conducted throughout Guinea in April 2024 to evaluate the extent of the spread of EACMV-Ug in the country and to collect critical CMD epidemiological data. Findings showed a high whitefly population in Lower Guinea averaging 17 per plant; however, the data suggest a spread of EACMV-Ug via infected cuttings. High CMD incidence was found in Lower Guinea and Forest Guinea, whereas the highest CMD severity was observed in Forest Guinea (2.70 ± 0.06) and the lowest CMD severity was found in Middle Guinea (2.20 ± 0.05). Several cases of double and triple infections involving African cassava mosaic virus, East African cassava mosaic virus, East African cassava mosaic Cameroon virus, and EACMV-Ug were observed. EACMV-Ug was detected throughout Guinea, as well as from samples collected in 2022 in Kambia (Sierra Leone). The 63 accessions cultivated in Guinea that were assessed in this study were found susceptible to at least one of the viruses cited above. This study alerts us to an alarming situation in development in West Africa and provides scientific evidence to guide the rapid response needed to contain and stop the progression of EACMV-Ug in West Africa.

An estimated 80% of persons in the world depend on medicinal plants for their healthcare needs. It is essential to study these plants in a bid to evaluate their therapeutic properties, adding credence to their applications in folklore. In this study, we report the antioxidant and antibiotic properties of Bixa Orellana (BO) and Milicia excelsa (ME) against Staphylococcus aureus isolates. Antioxidant profile, Total phenol content and total flavonoid content of both plants were performed using standard methods. Also, methanolic extracts of Bixa orellana and Milicia excelsa prepared in concentrations ranging from 3.125 mg/ml to 100 mg/ml were assessed for their antimicrobial activity using the agar well diffusion method. Total phenol content was 1.039 mg/g and 1.032 mg/g while total flavonoid content was 0.76mg/g and 0.5mg/g for Milicia excelsa and Bixa Orellana respectively. Both plant extracts also showed good free radical scavenging ability. The S. aureus isolates showed a dose-dependent sensitivity to the test extracts with sensitivity reducing at lower concentrations. Bixa Orellana showed better activity than Milicia excelsa. However, Milicia excelsa inhibited more organisms at lower concentrations (≤25 mg/ml). This study has shown the efficacy of both plants as alternative herbal treatments.

Introduction: Plasmodium falciparum has developed resistance to artemisinin drugs in Southeast Asia, and its reduced sensitivity has been reported in other regions. This study aims to determine parasite susceptibility to the bioactive form of artemisinin derivatives- dihydroartemisinin (DHA)-, and to detect the K13 polymorphism in isolates from an endemic area of Nigeria. Methods: Ex-vivo response in 55 parasites isolates obtained from malaria-positive patients were exposed to pulse DHA concentration and cultured for 66 hours ex-vivo. Parasite ring stage survival (RSAex-vivo) relative to unexposed matched control was determined by microscopy, and parasite growth was compared using Mann-Whitney U-test at a significance level of P<0.05. The Kelch propeller gene was amplified using specific primers, then sequenced and analyzed for single nucleotide polymorphisms (SNPs), which were compared to reference PF3D7_1343700. Results: Overall, 151 of 375 (40.2%) individuals were positive during the study period. In 55 selected isolates, there was increased growth in unexposed wells but growth was inhibited in DHA-exposed wells, with growth rate between 14.9 – 96.7%. The mean RSAex-vivo value was 0.18 ± 0.09%, 95% CI (0.15-0.20). There was no significant mutation of the K13 gene in the parasite isolates evaluated. Conclusions: Plasmodium falciparum isolates from this endemic area show high sensitivity to dihydroartemisinin ex-vivo, with no mutations conferring artemisinin resistance. Continuous monitoring of parasite susceptibility to artemisinin combination drugs should be intensified to reduce chances of artemisinin resistance in endemic areas.